Global Biologic Therapeutics Market 2021-2025

The publisher has been monitoring the biologic therapeutics market and it is poised to grow by $226.61 bn during 2021-2025, progressing at a CAGR of 11.00% during the forecast period. Our report on the biologic therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by strong R&D pipeline, patent expiry of major biologics, and increasing investment in development of biologics.

The biologic therapeutics market analysis includes product and geographic landscape.

The biologic therapeutics market is segmented as below:

By Product

Antibody therapeutics
Vaccines
Cell therapy
Gene therapy
Other therapies

By Geographical Landscape

North America
Europe
Asia
ROW

This study identifies the introduction of biosimilars as one of the prime reasons driving the biologic therapeutics market growth during the next few years. Also, the increasing incidence of chronic diseases and immunological disorders and patent expiry of major biologics will lead to sizable demand in the market.

The report on biologic therapeutics market covers the following areas:

Biologic therapeutics market sizing
Biologic therapeutics market forecast
Biologic therapeutics market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biologic therapeutics market vendors that include AbbVie Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., and Sanofi SA. Also, the biologic therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Executive Summary

Market overview

Market Landscape

Market ecosystem
Value chain analysis

Market Sizing

Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Product

Market segments
Comparison by Product
Antibody therapeutics - Market size and forecast 2020-2025
Vaccines - Market size and forecast 2020-2025
Cell therapy - Market size and forecast 2020-2025
Gene therapy - Market size and forecast 2020-2025
Other therapies - Market size and forecast 2020-2025
Market opportunity by Product

Customer landscape

Geographic Landscape

Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape

Overview
Landscape disruption

Vendor Analysis

Vendors covered
Market positioning of vendors
AbbVie Inc.
AstraZeneca Plc
Bristol-Myers Squibb Co.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
Johnson and Johnson Inc.
Merck and Co. Inc.
Novartis AG
Pfizer Inc.
Sanofi SA

Appendix

Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

List of Exhibits

Key Finding 1
Key Finding 2
Key Finding 3
Key Finding 5
Key Finding 6
Key Finding 7
Key Finding 8
Parent market
Market characteristics
Offerings of vendors included in the market definition
Market segments
Global - Market size and forecast 2020 - 2025 ($ billion)
Global market: Year-over-year growth 2020 - 2025 (%)
Five forces analysis 2020 & 2025
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition - Five forces 2020
Product - Market share 2020-2025 (%)
Comparison by Product
Antibody therapeutics - Market size and forecast 2020-2025 ($ billion)
Antibody therapeutics - Year-over-year growth 2020-2025 (%)
Vaccines - Market size and forecast 2020-2025 ($ billion)
Vaccines - Year-over-year growth 2020-2025 (%)
Cell therapy - Market size and forecast 2020-2025 ($ billion)
Cell therapy - Year-over-year growth 2020-2025 (%)
Gene therapy - Market size and forecast 2020-2025 ($ billion)
Gene therapy - Year-over-year growth 2020-2025 (%)
Other therapies - Market size and forecast 2020-2025 ($ billion)
Other therapies - Year-over-year growth 2020-2025 (%)
Market opportunity by Product
Customer landscape
Market share By Geographical Landscape 2020-2025 (%)
Geographic comparison
North America - Market size and forecast 2020-2025 ($ billion)
North America - Year-over-year growth 2020-2025 (%)
Europe - Market size and forecast 2020-2025 ($ billion)
Europe - Year-over-year growth 2020-2025 (%)
Asia - Market size and forecast 2020-2025 ($ billion)
Asia - Year-over-year growth 2020-2025 (%)
ROW - Market size and forecast 2020-2025 ($ billion)
ROW - Year-over-year growth 2020-2025 (%)
Key leading countries
Market opportunity By Geographical Landscape ($ billion)
Impact of drivers and challenges
Vendor landscape
Landscape disruption
Industry risks
Vendors covered
Market positioning of vendors
AbbVie Inc. - Overview
AbbVie Inc. - Product and service
AbbVie Inc. - Key offerings
AbbVie Inc. - Key customers
AbbVie Inc. - Segment focus
AstraZeneca Plc - Overview
AstraZeneca Plc - Product and service
AstraZeneca Plc - Key offerings
AstraZeneca Plc - Key customers
AstraZeneca Plc - Segment focus
Bristol-Myers Squibb Co. - Overview
Bristol-Myers Squibb Co. - Product and service
Bristol-Myers Squibb Co. - Key offerings
Bristol-Myers Squibb Co. - Key customers
Bristol-Myers Squibb Co. - Segment focus
F. Hoffmann-La Roche Ltd. - Overview
F. Hoffmann-La Roche Ltd. - Business segments
F. Hoffmann-La Roche Ltd. - Key offerings
F. Hoffmann-La Roche Ltd. - Key customers
F. Hoffmann-La Roche Ltd. - Segment focus
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Key customers
GlaxoSmithKline Plc - Segment focus
Johnson and Johnson Inc. - Overview
Johnson and Johnson Inc. - Business segments
Johnson and Johnson Inc. - Key offerings
Johnson and Johnson Inc. - Key customers
Johnson and Johnson Inc. - Segment focus
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Key customers
Merck and Co. Inc. - Segment focus
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key offerings
Novartis AG - Key customers
Novartis AG - Segment focus
Pfizer Inc. - Overview
Pfizer Inc. - Business segments
Pfizer Inc. - Key offerings
Pfizer Inc. - Key customers
Pfizer Inc. - Segment focus
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key offerings
Sanofi SA - Key customers
Sanofi SA - Segment focus
Currency conversion rates for US$
Research Methodology
Validation techniques employed for market sizing
Information sources
List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global biologic therapeutics market: AbbVie Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., and Sanofi SA.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is the introduction of biosimilars.`

According to the report, one of the major drivers for this market is the strong R&D pipeline.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.